Patents by Inventor Deborah L. Kilpatrick

Deborah L. Kilpatrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7842012
    Abstract: A guidewire with a sensor which can detect NO and/or superoxide levels is disclosed. This invention can be useful for in vivo analysis of vascular health.
    Type: Grant
    Filed: February 3, 2006
    Date of Patent: November 30, 2010
    Assignee: Advanced Cardiovascular Systems, Inc.
    Inventors: Jeffrey T. Ellis, Robert D. Ainsworth, Deborah L. Kilpatrick, Alex Q. Tilson, Bridget A. Hurley
  • Publication number: 20090326574
    Abstract: A method of treating vulnerable plaque comprising intentionally damaging or rupturing the vulnerable plaque using a wingless balloon which is inflated from a wingless unexpanded diameter to a limited expanded diameter. This process produces significant increase in ECM synthesis at the site of the damage or rupture. As a result, the method strengthens the vulnerable plaque while minimizing or avoiding damage to the surrounding wall of the body lumen or damaging a stable plaque mistakenly believed to be a vulnerable plaque. The method of the invention is particularly useful in treating a fibroatheroma type of vulnerable plaque. In one embodiment, the balloon is self-limiting such that it expands compliantly at initial inflation pressures, and above nominal pressure it expands noncompliantly. In an alternative embodiment, the balloon is inflated using a diameter-limiting device, such as a device which limits the inflation pressure or the volume of inflation fluid in the balloon.
    Type: Application
    Filed: June 17, 2009
    Publication date: December 31, 2009
    Inventors: Deborah L. Kilpatrick, Robert D. Ainsworth, Murthy V. Simhambhatla, Jeong S. Lee
  • Patent number: 7553292
    Abstract: A method of treating vulnerable plaque comprising intentionally damaging or rupturing the vulnerable plaque using a wingless balloon which is inflated from a wingless unexpanded diameter to a limited expanded diameter. This process produces significant increase in ECM synthesis at the site of the damage or rupture. As a result, the method strengthens the vulnerable plaque while minimizing or avoiding damage to the surrounding wall of the body lumen or damaging a stable plaque mistakenly believed to be a vulnerable plaque. The method of the invention is particularly useful in treating a fibroatheroma type of vulnerable plaque. In one embodiment, the balloon is self-limiting such that it expands compliantly at initial inflation pressures, and above nominal pressure it expands noncompliantly. In an alternative embodiment, the balloon is inflated using a diameter-limiting device, such as a device which limits the inflation pressure or the volume of inflation fluid in the balloon.
    Type: Grant
    Filed: May 26, 2005
    Date of Patent: June 30, 2009
    Assignee: Advanced Cardiovascular Systems, Inc.
    Inventors: Deborah L. Kilpatrick, Robert D. Ainsworth, Murthy V. Simhambhatla, Jeong S. Lee
  • Patent number: 7025734
    Abstract: A guidewire with a sensor which can detect NO and/or superoxide levels is disclosed. This invention can be useful for in vivo analysis of vascular health.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: April 11, 2006
    Assignee: Advanced Cardiovascular Systmes, Inc.
    Inventors: Jeffrey T. Ellis, Robert D. Ainsworth, Deborah L. Kilpatrick, Alex Q. Tilson, Bridget A. Hurley
  • Patent number: 6972024
    Abstract: A method of treating vulnerable plaque comprising intentionally damaging or rupturing the vulnerable plaque using a wingless balloon which is inflated from a wingless unexpanded diameter to a limited expanded diameter. This process produces significant increase in ECM synthesis at the site of the damage or rupture. As a result, the method strengthens the vulnerable plaque while minimizing or avoiding damage to the surrounding wall of the body lumen or damaging a stable plaque mistakenly believed to be a vulnerable plaque. The method of the invention is particularly useful in treating a fibroatheroma type of vulnerable plaque. In one embodiment, the balloon is self-limiting such that it expands compliantly at initial inflation pressures, and above nominal pressure it expands noncompliantly. In an alternative embodiment, the balloon is inflated using a diameter-limiting device, such as a device which limits the inflation pressure or the volume of inflation fluid in the balloon.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: December 6, 2005
    Assignee: Advanced Cardiovascular Systems, Inc.
    Inventors: Deborah L. Kilpatrick, Robert D. Ainsworth, Murthy V. Simhambhatla, Jeong S. Lee
  • Patent number: 6541116
    Abstract: A method of providing a therapeutic, diagnostic or lubricious hydrophilic coating on an intracorporeal medical device and the coated device produced thereby, wherein the coating is durable. In one embodiment, the coating comprises a polymerized base coat and a top coat having a therapeutic, diagnostic or hydrophilic agent, where the base coat has a binding component which binds to the top coat, and a grafting component which binds to the binding component and adheres to the device. In another embodiment, the coating comprises a blend of an agent, a grafting component, and salt. In one embodiment, the therapeutic agent is superoxide dismutase or a superoxide dismutase mimic. The coating of the invention may be applied to a medical device with a polymeric surface such as a polymeric catheter, or a metal device such as a stent coated with a polymeric primer or without a primer.
    Type: Grant
    Filed: April 6, 2001
    Date of Patent: April 1, 2003
    Assignee: Advanced Cardiovascular Systems, Inc.
    Inventors: Eugene T. Michal, Christopher J. Buchko, Deborah L. Kilpatrick, Stephen J. Bigus
  • Publication number: 20020009535
    Abstract: A method of providing a therapeutic, diagnostic or lubricious hydrophilic coating on an intracorporeal medical device and the coated device produced thereby, wherein the coating is durable. In one embodiment, the coating comprises a polymerized base coat and a top coat having a therapeutic, diagnostic or hydrophilic agent, where the base coat has a binding component which binds to the top coat, and a grafting component which binds to the binding component and adheres to the device. In another embodiment, the coating comprises a blend of an agent, a grafting component, and salt. In one embodiment, the therapeutic agent is superoxide dismutase or a superoxide dismutase mimic. The coating of the invention may be applied to a medical device with a polymeric surface such as a polymeric catheter, or a metal device such as a stent coated with a polymeric primer or without a primer.
    Type: Application
    Filed: April 6, 2001
    Publication date: January 24, 2002
    Applicant: Advanced Cardiovascular Systems, Inc.
    Inventors: Eugene T. Michal, Christopher J. Buchko, Deborah L. Kilpatrick, Stephen J. Bigus